Updates on CCP Virus: Pfizer Launches Trial to Evaluate Vaccine in Pregnant Women

A health worker displays a dose of the Pfizer-BioNTech COVID-19 vaccine at Robert Ballanger hospita in Aulnay-sous-Bois, north of Paris, France, on Jan.6, 2021. Christophe Archambault/Pool Photo via AP

Pfizer and its partner company said this week that they’re launching a clinical trial to see if their CCP virus vaccine is safe and effective for pregnant women.

The phase 2/3 study will test approximately 4,000 healthy, pregnant women 18 years of age or older, according to Pfizer and BioNTech. The women will get the shot between 24 to 34 weeks of gestation in the randomized, placebo-controlled, observer-blind trial.

US Extends Travel Restrictions at Land Borders

U.S. land borders with Canada and Mexico will remain closed to non-essential travel until at least March 21, the one-year anniversary of the restrictions to address CCP (Chinese Communist Party) virus transmission concerns, the U.S. government said Friday.